Showing 141 - 160 results of 349 for search '"pharmacotherapy"', query time: 0.05s Refine Results
  1. 141

    The Clinical Significance of Exhaled Nitric Oxide in Asthma by Sachin Pendharkar, Sanjay Mehta

    Published 2008-01-01
    “…Guidelines for the management of asthma suggest a stepwise approach to pharmacotherapy based on assessment of asthma severity and control. …”
    Get full text
    Article
  2. 142

    Less common forms of diabetes in young population by Anna Tekielak, Ewa Otto-Buczkowska, Ewa Rusak

    Published 2024-03-01
    “…In therapy, lifestyle modification is essential for weight loss, and if this is not enough, pharmacotherapy is required. Maturity-onset diabetes of the young (MODY), another type of insulin-dependent diabetes, is characterised by early onset and autosomal dominant inheritance. …”
    Get full text
    Article
  3. 143

    Absence of Standard Modifiable Risk Factors in Middle Eastern Patients with Atherosclerotic Cardiovascular Disease. The Jordan Absence of Standard Modifiable Risk Factors (SMuRF-Le... by Hammoudeh AJ, Aldalal’ah M, Smadi EA, Alrishoud D, Alomari A, Alkhawaldeh M, Rizik A, Okour MF, Araydah M

    Published 2025-02-01
    “…SMuRF-less patients were younger, had less comorbid disease, received less secondary prevention pharmacotherapy and had higher rate of one year mortality than those with SMuRFs.Clinical Trials: The study is registered with ClinicalTrials.gov, unique identifier number NCT06199869.Keywords: atherosclerotic cardiovascular disease, standard modifiable risk factors, SMuRF-less patients, Middle Eastern patients…”
    Get full text
    Article
  4. 144

    Brain-targeting drug delivery systems: The state of the art in treatment of glioblastoma by Bo Sun, Rong Li, Ning Ji, Han Liu, Hongxiang Wang, Chao Chen, Long Bai, Jiacan Su, Juxiang Chen

    Published 2025-02-01
    “…This emphasis has driven the exploration and evaluation of diverse technologies for GBM pharmacotherapy, with some already undergoing clinical trials. …”
    Get full text
    Article
  5. 145

    Zinc Transporters, Mechanisms of Action and Therapeutic Utility: Implications for Type 2 Diabetes Mellitus by Stephen A. Myers, Alex Nield, Mark Myers

    Published 2012-01-01
    “…This previously unexplored concept would raise a whole new area of research into the pathophysiology of insulin resistance and introduce a new class of drug target with utility for diabetes pharmacotherapy.…”
    Get full text
    Article
  6. 146
  7. 147

    Viloxazine, a Non-stimulant Norepinephrine Reuptake Inhibitor, for the Treatment of Attention Deficit Hyperactivity Disorder: A 3 Year Update by Hannah W Haddad, Paul B. Hankey, Jimin Ko, Zahaan Eswani, Pravjit Bhatti, Amber N. Edinoff, Adam M. Kaye, Alan D. Kaye

    Published 2022-07-01
    “…Viloxazine appears to be a suitable alternative to current standard-of-care pharmacotherapy for ADHD, but the further investigation remains to be done in comparing its efficacy to that of current treatments.…”
    Get full text
    Article
  8. 148

    Motion-Cyclo-oxygenase-2 Selective Nonsteroidal Anti-Inflammatory Drugs are as Safe as Placebo for the Stomach: Arguments for the Motion by Richard H Hunt

    Published 2003-01-01
    “…Coxibs are an important addition to the pharmacotherapy of inflammatory disease.…”
    Get full text
    Article
  9. 149

    New Aspects in the Differential Diagnosis and Therapy of Bladder Pain Syndrome/Interstitial Cystitis by Jochen Neuhaus, Thilo Schwalenberg, Lars-Christian Horn, Henry Alexander, Jens-Uwe Stolzenburg

    Published 2011-01-01
    “…Although more research is needed to elucidate the pathomechanisms involved, extended BPS/IC diagnostics could already be integrated into routine patient care, allowing evidence-based pharmacotherapy of patients with idiopathic bladder overactivity and BPS/IC.…”
    Get full text
    Article
  10. 150

    Behavioral Activation (BA) in the Management of Depression in an Adolescent with Down Syndrome in Dubai by Sidra Shadan, Sarah Almarzooqi, Meshal A. Sultan

    Published 2021-01-01
    “…Depression has been commonly treated with psychotherapy and/or pharmacotherapy for several decades. Ongoing research in the field has suggested promise for behavioral activation (BA), a form of psychotherapeutic intervention, as a means of increasing engagement in adaptive activities and developing skills to counter avoidance in individuals suffering from depression. …”
    Get full text
    Article
  11. 151

    Meta-cognitive Therapy in Obsessive Compulsive Disorder: A Case Report by Ayushi Gaur, Shivali Sharma, Shweta Singh

    Published 2025-01-01
    “…The present case report provides a detailed insight into the psychotherapeutic treatment using MCT, in which 10 sessions were provided to an OCD patient along with pharmacotherapy. The treatment shows a noteworthy improvement in thought fusion, obsessional beliefs, meta-cognitive beliefs, and psychopathology. …”
    Get full text
    Article
  12. 152

    Psychiatric and Behavioral Complications of GPi DBS in an Adolescent with Myoclonus Dystonia by Graciela Kriegel, Melanie I. Stuckey

    Published 2019-01-01
    “…Deep brain stimulation of the internal pallidum (GPi DBS) is a recommended treatment for those who do not respond to pharmacotherapy or who have intolerable side effects. …”
    Get full text
    Article
  13. 153

    Mirtazapine Treatment of a Severe Depressive Episode and Resolution of Elevated Inflammatory Markers by Shahzad M. Alikhan, Jessica A. Lee, Luiz Dratcu

    Published 2013-01-01
    “…This report describes an association between a clinical antidepressant response and a decrease in markers of systemic inflammation observed during pharmacotherapy with mirtazapine in a severely depressed but physically well patient. …”
    Get full text
    Article
  14. 154

    Utilisation of alcohol-related treatment after a first alcohol use disorder diagnosis in Hamburg, Germany by Jakob Manthey, Kilian Huß, Sven Buth, Ludwig Kraus, Anna Schranz, Carolin Kilian, Jürgen Gallinat, Ingo Schäfer, Bernd Schulte

    Published 2025-01-01
    “…Formal psychotherapy, low-threshold counselling, and pharmacotherapy were rarely utilised and were mostly used in conjunction with other treatments. …”
    Get full text
    Article
  15. 155

    Exploration of non-pharmacological interventions in the management of behavioural and psychological symptoms of dementia by Nur Sabiha Md Hussin, Mahmathi Karuppannan, Yogheswaran Gopalan, Kit Mun Tan, Shubashini Gnanasan

    Published 2023-08-01
    “…Introduction: Behavioural and psychological symptoms of dementia (BPSD) are considered integral parts of dementia. While pharmacotherapy is reserved for severe symptoms of BPSD, the associated adverse effects can be detrimental. …”
    Get full text
    Article
  16. 156

    Characterization and taste masking evaluation of microparticles with cetirizine dihydrochloride and methacrylate-based copolymer obtained by spray drying by Amelian Aleksandra, Szekalska Marta, Ciosek Patrycja, Basa Anna, Winnicka Katarzyna

    Published 2017-03-01
    “…Taste of a pharmaceutical formulation is an important parameter for the effectiveness of pharmacotherapy. Cetirizine dihydrochloride (CET) is a second-generation antihistamine that is commonly administered in allergy treatment. …”
    Get full text
    Article
  17. 157

    Insulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic Disorders by A. Janus, E. Szahidewicz-Krupska, G. Mazur, A. Doroszko

    Published 2016-01-01
    “…Combined and expletive treatment of hypertension, lipid disorders, and insulin resistance with nonpharmacological interventions and conventional pharmacotherapy may inhibit the transformation of metabolic disturbances to fully developed cardiovascular disease. …”
    Get full text
    Article
  18. 158

    A case of acute labyrinthitis due to intra-aural tick infestation: a case report by Ankita Shah, Deepak Paudel, Aman Shah

    Published 2025-01-01
    “…Treatment involved careful tick removal using suction and forceps, supplemented by pharmacotherapy including antiinflammatory agents, analgesics, systemic steroids, and prophylactic antibiotics. …”
    Get full text
    Article
  19. 159

    Therapeutic Applicability of Anti-Inflammatory and Proresolving Polyunsaturated Fatty Acid-Derived Lipid Mediators by Gerard L. Bannenberg

    Published 2010-01-01
    “…Different aspects of the therapeutic applicability of lipid mediators have been addressed here, and indicate that the development of innovative pharmacotherapy based on anti-inflammatory and proresolution lipid mediators presents novel prospects for the treatment of inflammatory disease.…”
    Get full text
    Article
  20. 160

    Persistent postural-perceptual dizziness: a review of current knowledge on vestibular rehabilitation by Samer Sami Azeez, Ebtessam H. Nada

    Published 2025-01-01
    “…Additionally, the lack of established treatment protocols necessitates a multifaceted approach that may include pharmacotherapy, vestibular rehabilitation therapy (VRT), and psychological interventions. …”
    Get full text
    Article